Medpace Core Laboratories is Pleased to Announce A Successfully Completed Inspection by the FDA
Medpace Core Laboratories successfully completed a comprehensive inspection by the FDA on a late phase, registrational, oncology trial. The inspection concluded with no major or…
4 Key Considerations for Designing Immuno-Oncology Trials
As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of…
Q&A with NASH Imaging Expert Dr. Mustafa Bashir
Medpace Imaging Core Laboratory, Associate Director, Dr. Scott Holland, had an opportunity to sit down with Dr. Bashir to discuss all things NASH imaging. In the…
Rheumatoid Arthritis Imaging: an Interview with Dr. Sharmila Majumdar
Dr. Sharmila Majumdar discusses the opportunities and challenges of rheumatoid arthritis imaging with Scott Holland, PhD, Associate Director of Medpace Imaging Core Laboratory, in this timely…
Imaging Biomarkers for Autoimmune Diseases
Medpace Imaging Core Lab has experience and expertise in autoimmune imaging using conventional and molecular imaging methods.
Interview with Dr. Marco Tangelder: New Developments in the Clinical Development Landscape for Ophthalmology
Ophthalmology is a growing therapeutic area in clinical research with new and exciting developments occurring in the field, particularly in stem cell and gene cell…
How Rare Diseases Are Showing the Way Toward Precision Medicine – Part 3
In our previous post, we discussed the approaches to help you identify, enroll and retain rare disease populations in clinical trials. Once the right patients…